Hyperpigmentation as a peculiar presentation of mycosis fungoides
Lu, Ying-Yi; Wu, Chieh-Hsin; Lu, Chun-Ching; Hong, Chien-Hui.
An. bras. dermatol
; 92(5,supl.1): 92-94, 2017. graf
Artículo en Inglés | LILACS | ID: biblio-887103
Documentos relacionados
Differential Response of Mycosis Fungoides Cells to Vorinostat.
Impact of blood involvement on efficacy and time to response with mogamulizumab in mycosis fungoides and Sézary syndrome.
Chlormethine Gel for the Treatment of Mycosis Fungoides (Cutaneous T-cell Lymphoma) in Canada.
Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study.
Interferon α-induced lupus-like reaction in a mycosis fungoides patient: A case report.
Utility of Low-Dose Duvelisib for Advanced Mycosis Fungoides: A Single-Institution Study.
Possible effects of plasminogen activator inhibitor-1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides.
[Low-frequency, low-dose oral psoralen-UV-A therapy for mycosis fungoides].
Treatment of early-stage mycosis fungoides with oral bexarotene and phototherapy: A systematic review and meta-analysis.
Low-dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T-cell lymphoma.